Speakers: Michele Smith MS SCT(ASCP) & Diane Davis Davey, MD
ASCCP Screening Guidelines: https://www.asccp.org/screening-guidelines
ASCCP Mobile App: https://www.asccp.org/mobile-app
ACS Cervical Cancer Updates: https://www.cancer.org/latest-news/acs-updates-cervical-cancer-screening-guidelines-to-start-screening-at-age-25.html
HPV Primary Platforms:
Roche cobas HPV: https://diagnostics.roche.com/us/en/products/params/cobas-hpv.html
BD Onclarity HPV: https://www.bd.com/en-us/offerings/capabilities/cervical-cancer-screening/onclarity-hpv-assay
Co-Testing:
Hologic Cotesting: https://www.hologic.com/about/hologic-highlights/screening-cervical-cancer-pap-and-hpv-testing-combined
Hologic Aptima: https://www.hologic.com/hologic-products/diagnostic-solutions/aptimathinprep-cervical-health
Hologic Cervista: https://www.hologic.com/package-inserts/diagnostic-products/cervista-hpv-hr-assay
BD SurePath: https://www.bd.com/en-us/offerings/capabilities/cervical-cancer-screening/cervical-sample-collection/surepath-liquid-based-pap-test
Articles attached:
Primary HPV Screen Only? Experts warn of risks. Ann Paxon from Cap Today
Cytopathology in focus: Abnormal Cervical Screening Tests: a personal approach. Barb Crothers and Diane Davey from Cap Today
Moving forward the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories from JASC (2020) 9, 291-303.
Create your
podcast in
minutes
It is Free